NCT07393958

Impact of Food Supplementation on Quality of Life in Patients With Endometriosis and Pelvic Pain.

Experimental Study of Quality of Life in Patients With Endometriosis and Pelvic Pain Treated With Doliral Dietary Supplementation Versus Placebo.

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Arafarma Group, S.A. · Industry
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study examines whether the food supplement Doliral can improve quality of life and reduce pelvic pain in women with endometriosis, compared with placebo, over several weeks.

Detailed description

Patients included into the study will be randomized into two treatment groups (30:30 patients). 30 patients will be treated with the food supplement and 30 patients will be treated with placebo. Both groups will be stratified by the presence or absence of hormonal therapy. Patients will be required to attend 6 study visits (selection visit, baseline or visit 0, and visits 1, 2, 3 and final or visit 4). Patients will complete a daily endometriosis symptom diary, which also includes a record of anti-inflammatory and paing medication use. Study treatment will be administred at Visit 0 or Baseline until Visit 4 or Final. At the study visits, patients will be requested to confirm the pain intensity through the VAS scale for different endometriosis pain types. They will be also requested to complete several questionnaires about quality of life.

Conditions

• Endometriosis (Diagnosis)

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Food supplement (T1675)	Doliral is the food supplement, which is the investigational product at this study.
OTHER	Placebo	Placebo is the control treatment.

Timeline

• Start date: 2026-02-26
• Primary completion: 2026-08-01
• Completion: 2026-09-15
• First posted: 2026-02-06
• Last updated: 2026-03-02

Locations

1 site across 1 country: Spain